SEC Filing Details

Document Details

Form
3
Filing Date
February 4, 2021
Document Date
February 4, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Bolt Biotherapeutics
Issuer
Bolt Biotherapeutics, Inc.
Filer
Schatzman Randall C